Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
NSAID; COX-1/2 and lipoxygenase inhibitor.
Endogenous amino acid sugar involved in cartila...
Indoline; PDGFR, VEGFR, c-KIT, FLT3, mTORC1 inh...
HIV protease, GLUT4, calpain inhibitor.
Peptide, IgG derivative, tuftsin analog.
Purine derivative; CDK inhibitor.
GHB/GABA analog found in Valeriana officinalis;...
Nicotinamide analog prodrug; fatty acid synthet...
Mixture of glycopeptide bleomycin sulfate salts...
SGLT2 inhibitor
2-methyl-1,4-naphthoquinone derivative
pan-RAF inhibitor
Endogenous peptide hormone, increases extracell...
β-adrenergic agonist.
GABA analog; GABA potentiator, adenosine A1 ago...
Potential PKD binding agent.
Potential p53 activator or SIRT2 inhibitor.
FGFR inhibitor.
Marine toxin; actin polymerization inducer.
STING antagonist